Blueprint Medicines (BPMC)
(Delayed Data from NSDQ)
$93.00 USD
+2.27 (2.50%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $93.00 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth C Momentum F VGM
Earnings News For BPMC
-
Blueprint Medicines (BPMC) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
-
Blueprint (BPMC) Q4 Earnings Beat, Stock Up as Ayvakit Shines
-
Blueprint Medicines (BPMC) Reports Q4 Loss, Tops Revenue Estimates
-
Blueprint Medicines: Q4 Earnings Snapshot
-
Blueprint Medicines Reports Fourth Quarter and Full Year 2023 Results
-
Blueprint Medicines (BPMC) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
-
Blueprint (BPMC) Stock Gains 26% on Q3 Earnings & Sales Beat
-
Blueprint Medicines (BPMC) Reports Q3 Loss, Tops Revenue Estimates
-
Blueprint Medicines: Q3 Earnings Snapshot
-
Blueprint Medicines Reports Third Quarter 2023 Results
-
Earnings Preview: Blueprint Medicines (BPMC) Q3 Earnings Expected to Decline
-
Why Is Blueprint Medicines (BPMC) Down 2% Since Last Earnings Report?
-
Blueprint (BPMC) Q2 Earnings and Revenues Beat Estimates
-
Blueprint Medicines (BPMC) Reports Q2 Loss, Tops Revenue Estimates
-
Blueprint Medicines: Q2 Earnings Snapshot
-
Blueprint Medicines Reports Second Quarter 2023 Results
-
Blueprint's (BPMC) Q1 Earnings & Sales Top Estimates, View Up
-
Blueprint Medicines (BPMC) Reports Q1 Loss, Tops Revenue Estimates
-
Blueprint Medicines: Q1 Earnings Snapshot
-
Blueprint Medicines Reports First Quarter 2023 Results
-
Analysts Estimate Blueprint Medicines (BPMC) to Report a Decline in Earnings: What to Look Out for
-
Blueprint's (BPMC) Q4 Earnings & Sales Top Estimates, Stock Up
-
Blueprint Medicines (BPMC) Reports Q4 Loss, Tops Revenue Estimates
-
Blueprint Medicines: Q4 Earnings Snapshot
-
Blueprint Medicines: Q4 Earnings Snapshot